Valley Health System
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Valley Health System sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Valley Health System: 8 sponsored US clinical trials, 1 recruiting.
Valley Health System sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer Metastatic, with 1 trials.
Upper-quartile sponsor footprint
Valley Health System sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
NCT05232409
Comparison of Surgeons' Object Discernment Via Their Hands Versus Using a Robotic Surgical System That Does Not Incorporate Haptics
NCT06896084
Impact of a Structured Cardiac Rehabilitation Program on Cardiorespiratory Fitness in Patients With Atrial Fibrillation
NCT04092166
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib
NCT03811795
Impact of Swaddle Blanket on Gastroesophageal Reflux
NCT02083952
Barrett's Esophagus & Gastroesophageal Reflux Disease
NCT00513331
Preoperative Treatment of Patients With High Risk Thymoma
NCT00387868
Ten-year Outcomes After AF Ablation
NCT01867099
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Valley Health System pipeline
1 recruiting of 8 indexed (13% open); 7 completed (88%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Cancer Metastatic (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Valley Health System: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Valley Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this Valley Health System page
8 registered trials is a research-attention snapshot, not an endorsement of Valley Health System or any single study.
- 1 of Valley Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer Metastatic is the condition Valley Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer Metastatic trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Valley Health System pipeline card: 8 registered trials from official public datasets.Report a data error.